Antibiotic Resistance of Salmonella in Europe and the United States

Cherubin, Charles E.

doi:10.1093/clinids/3.6.1105

Cited by 47 publications

(21 citation statements)

References 79 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study, as well as other studies, proves that different serogroups have different patterns of resistance, with serogroups B4,5 and C7 usually being more resistant than serogroup Dg (6).…”

Section: Salmonella Infections Constitute An Important Problemsupporting

confidence: 85%

Antimicrobial resistance of Salmonella isolates in a Spanish hospital

Muñóz

Díaz

Rodríguez‐Créixems

et al. 1993

Antimicrob Agents Chemother

View full text Add to dashboard Cite

We studied 961 clinical Salmonella isolates (one per patient) seen in one Spanish hospital from 1988 to 1991. The incidence of non-Salmonella typhi SalmoneUla infections per 100,000 admissions increased from 3.93 to 5.98. Overall rates of resistance to ampicillin, chloramphenicol, and co-trimoxazole were 32, 11, and 2%, respectively. Resistance to chloramphenicol increased from 9 to 16% during the study period, while resistance to each of the other drugs remained stable. Variations related to serogroups were observed.

show abstract

Section: Salmonella Infections Constitute An Important Problemsupporting

confidence: 85%

Antimicrobial resistance of Salmonella isolates in a Spanish hospital

Muñóz

Díaz

Rodríguez‐Créixems

et al. 1993

Antimicrob Agents Chemother

View full text Add to dashboard Cite

show abstract

“…typhimurium is reported world-wide to be the most antibiotic-resistant serotype [6,7]. However, the reverse was observed in our sample: 4 7 % of S. typhimurium were resistant compared with 91 % of other serotypes.…”

Section: Discussioncontrasting

confidence: 59%

Antibiotic resistance among salmonella from human and other sources in New Zealand

Heffernan¹

1991

Epidemiol. Infect.

View full text Add to dashboard Cite

SUMMARYOf 2210 salmonella isolates referred to the New Zealand Communicable Disease Centre for epidemiological surveillance during 1987, 147 (6-7 %) were resistant to one or more of 10 antibiotics. Resistance to streptomycin was most common (4-5 %), followed by sulphamethoxazole (34%), tetracycline (33%), ampicillin (1P5%), and kanamycin (14%). Resistance to cephalothin, chloramphenicol, gentamicin and trimethoprim occurred in less than 1 % of isolates. There was no resistance to norfloxacin. Isolates from human sources were significantly (P < 000 1) more resistant (10%) than those from other sources (32 %). The majority of resistant isolates were resistant to more than one antibiotic, but multiresistance to five or more antibiotics occurred only among human isolates. Comparison of these results with data from earlier years shows that there has been little change in the incidence of resistance among salmonella in this country over the last 10 years. The prevalence of antibiotic resistance among salmonella in New Zealand is low relative to many other countries.

show abstract

“…The most severe, as well as the most frequently occurring, forms of this disease in developing countries are of bacterial origin (5). An increase in the frequency of antibiotic resistance of these organisms has been noted in developed as well as in developing countries (4,8,13). Therefore, continued concern about antimicrobial resistance is warranted, as are studies on the activity of new agents.…”

mentioning

confidence: 99%

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens

Goossens¹,

Mol²,

Coignau³

et al. 1985

Antimicrob Agents Chemother

View full text Add to dashboard Cite

The in vitro activity of drugs currently used in the treatment of diarrhea against 595 enteropathogens from worldwide sources was compared with that of six newly developed antibiotics, ciprofloxacin; norfloxacin; ofloxacin; aztreonam; HR810, an expanded-spectrum cephalosporin; and RU28965, a new macrolide. In contrast with ampicillin and chloramphenicol, trimethoprim-sulfamethoxazole showed an excellent activity against all of the enteropathogens tested, except Campylobacter species. Ciprofloxacin had the highest activity, with an overall 90% MIC of less than or equal to 0.097 micrograms/ml, except for Campylobacter species (0.39 micrograms/ml). Unlike other cephalosporins, HR810 showed a satisfactory activity against Campylobacter species (90% MIC of 3.12 micrograms/ml). RU28965 was three times less active than erythromycin against Campylobacter species.

show abstract

Antibiotic Resistance of Salmonella in Europe and the United States

Cited by 47 publications

References 79 publications

Antimicrobial resistance of Salmonella isolates in a Spanish hospital

Antimicrobial resistance of Salmonella isolates in a Spanish hospital

Antibiotic resistance among salmonella from human and other sources in New Zealand

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens

Contact Info

Product

Resources

About